Premium
Activation of the TCL1 protein in B cell lymphomas
Author(s) -
Nakayama Ichiro,
Murao Shinichi,
Kitazawa Sohei,
Azumi Atsushi,
Yamamoto Misao,
Maeda Sakan
Publication year - 2000
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1046/j.1440-1827.2000.01023.x
Subject(s) - lymphoma , mantle cell lymphoma , pathology , lymphoplasmacytic lymphoma , immunohistochemistry , b cell , biology , follicular lymphoma , cell , cancer research , medicine , antibody , immunology , waldenstrom macroglobulinemia , genetics
The TCL1 gene, localized near the break point of chromosome 14q32.1 often involved in T cell leukemias, is also expressed in normal precursor T and B cells, and B cell lymphoma cell lines. We investigated the expression of the TCL1 protein in various types of B cell lymphomas according to the Revised European–American Classification of Lymphoid neoplasms. Paraffin‐embedded tissue sections of lymphoma specimens were subjected to TCL1 immunohistochemistry, and positivity was scored on a three‐tiered scale: – ( < 25% cells), + (25–50% cells), and ++ ( > 50% cells). The TCL1 protein was expressed in low‐grade B cell lymphomas including mucosa‐associated lymphoid tissue type in ocular adnexa (18/20, 90%). It was also expressed in follicular, lymphoplasmacytic, and mantle cell lymphoma, but not in high‐grade diffuse large B cell lymphoma (2/11, 18%). These data suggest that the expression of the TCL1 gene characterizes low‐grade B cell lymphomas, and may be involved in certain processes of lymphomatogenesis.